Companies / PCK

PAINCHEK LTD

ASX:PCKHealth Care Equipment & ServicesSuspended from quotation
209.0M shares on issueASX (delayed) · as of 28 July 2026$0.12price · delayed$21.9Mmarket cap · indicative
NR
Dilution grade

Not rated — the company is suspended from quotation

Cash runwayno data — suspended — grade not computed
Share-count growth (24m)no data — suspended — grade not computed
Raise cadence (24m)0 cash raises
Options & rights overhangno dataconsolidation-adjusted
In-the-money supplyno data — no recent share price on record
Pending proposed issuesnone

PAINCHEK LTD's latest ordinary share count is 209M as of December 2025; a share consolidation of approximately 1-for-10 on October 2025 has been applied and the reported share count is consolidation-adjusted. Between disclosures the company recorded three capital raises in the 24-month window for total confirmed proceeds of A$12.6M, most recently raising A$7.5M in July 2025. There are no proposed securities issues (Appendix 3B) currently pending. At the March 2026 quarter the company reported A$5.6M in available cash. Options and rights data are not provided.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
1.4%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
2.3 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Adjusted for the 1-for-10 consolidation (24 Oct 2025). Latest count 209.0M per ASX (delayed) (28 July 2026).
208.8M208.9M209.0MDec 25Apr 26July 26

Cash runway

2.3 qtrs
Two to four quarters of funding at the recent spend rate.
$5.6M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
3 July 20263H · cancellationPCK : ORDINARY FULLY PAID209.0MAppendix 3H
26 June 20263G · unquotedPCK : ORDINARY FULLY PAID209.0MAppendix 3G
28 May 20263G · unquotedPCK : ORDINARY FULLY PAID209.0MAppendix 3G
14 Apr 20263H · cancellationPCK : ORDINARY FULLY PAID209.0MAppendix 3H
27 Mar 20263H · cancellationPCK : ORDINARY FULLY PAID209.0MAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

3 cash raises in the last 24 months · 0 in the last 12 months

$7.5M
Capital raise
23 July 2025
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

consolidation-adjusted Figures rebased for the share consolidation in the last 24 months.

1.4%
Total overhang · of current shares
0.0%
In the money · at current price
3.0M
Potential new shares
Sept 2029
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
19 June 2026Philip DaffasOther———3Y notice
19 June 2026Adam DaveyOther———3Y notice
19 June 2026Cynthia PayneOther———3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

21 July 2026$PPainChek receives $1.123 million R&D tax incentive refund
19 July 2026$PUS MedTech leader Karen Holzberger appointed CEO
8 July 2026Final Director's Interest Notice
6 July 2026$PCEO Transition
3 July 2026Notification of cessation of securities - PCK
26 June 2026Change of Director's Interest Notice x5
26 June 2026Notification regarding unquoted securities - PCK
3 June 2026PainChek secures initial Sabra US care facilities
28 May 2026Notification regarding unquoted securities - PCK
26 May 2026Initial Director's Interest Notice
24 May 2026Lil Bianchi appointed Non-Executive Chair of PainChek
22 May 2026Proposed issue of securities - PCK
21 May 2026$PPainChek secures A$5.5m note to fund US expansion
30 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
14 Apr 2026Notification of cessation of securities - PCK
13 Apr 2026$PLandmark Sabra North America deployment targeting 20k beds
27 Mar 2026Notification of cessation of securities - PCK
25 Mar 2026$PPainChek reports material sales momentum in UK
23 Mar 2026PainChek to present at NWR Virtual Healthcare Conference
3 Mar 2026Notification of cessation of securities - PCK

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.